Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fallon, Daniel
NCT05081245: ML-004 in Adolescents and Adults with Autism Spectrum Disorders (ASD)	Recruiting	2	150	Canada, US, RoW	ML-004 (IR)/(ER) tablet, ML-004 Placebo	MapLight Therapeutics	Autism Spectrum Disorder	03/25	04/25
Bannon, Yvonne
NCT05711940: Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD	Recruiting	3	568	Europe, Canada, US, RoW	Psilocybin, COMP360	COMPASS Pathways	Treatment Resistant Depression	03/25	05/25
NCT05642429: Study of AV-1959D, an Amyloid Beta Vaccine	Recruiting	1	48	US	AV-1959D, Placebo	Institute for Molecular Medicine, National Institute on Aging (NIA), Clinartis	Alzheimer Disease	02/26	11/26
ABT-CIP-10494, NCT06423430: Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)	Recruiting	N/A	100	US	Sham-stimulation, Active-stimulation	Abbott Medical Devices	Treatment Resistant Depression	04/27	04/29